BridgeMD
New treatment option for HPV (Human Papillomavirus)-Associated
Official title The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake
ClinicalTrials.gov ID: NCT07320157
What this study is testing
- What it's testing
- Type of Study: This study was planned to be an observational study. Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question(s) it aims to answer [is/are]: H1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomavirus (HPV) education and the control group women.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35, women only. Healthy volunteers may be eligible.
You may be able to join if
- Being female
- Women aged 18-35 years
- Ability to speak and understand Turkish at a level sufficient to communicate with the researcher
- Having the technical equipment necessary to participate in a video interview
- No diagnosis of HPV positivity
You likely can't join if
- Being male
- Having severe physical or cognitive impairments that prevent completing the questionnaire
- Being under 18 years of age or over 35 years of age
- Inability to speak or understand Turkish
- Lack of technical equipment to participate in a video interview
- Having a diagnosis of HPV positivity
See the full eligibility criteria
- Being female
- Women aged 18-35 years
- Ability to speak and understand Turkish at a level sufficient to communicate with the researcher
- Having the technical equipment necessary to participate in a video interview
- No diagnosis of HPV positivity
- Not having received the HPV vaccine
- Not having undergone HPV DNA/Pap smear testing in the past 5 years
- No diagnosis of cervical cancer
- Voluntary willingness to participate in the study
- No diagnosis of a psychiatric disorder
- Being male
- Having severe physical or cognitive impairments that prevent completing the questionnaire
- Being under 18 years of age or over 35 years of age
- Inability to speak or understand Turkish
- Lack of technical equipment to participate in a video interview
- Having a diagnosis of HPV positivity
- Having received the HPV vaccine
- Having undergone HPV DNA/Pap smear testing in the past 5 years
- Having a diagnosis of cervical cancer
- Having a diagnosed psychiatric disorder Not agreeing to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.